Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology
|
Buy Now
Neoplasms of the Liver (Paperback, Softcover reprint of the original 1st ed. 1987)
Loot Price: R1,640
Discovery Miles 16 400
|
|
Neoplasms of the Liver (Paperback, Softcover reprint of the original 1st ed. 1987)
Expected to ship within 10 - 15 working days
|
Primary liver cancer is a rather unusual malignancy in that the
incidence varies tremendously from one geographical area to
another. While relatively uncom mon in Western countries, it is the
most prevalent malignant neoplasm in Southeast Asia, South Africa,
and many other regions; in all, the countries in which primary
liver cancer is very prevalent account for more than two-thirds of
the world's population. In China alone, approximately 100 000
people die every year from primary liver cancer, mostly
hepatocellular carcinoma. The incidence is rising in some
countries, especially Japan, where it has doubled among males in
the past 15 years or so, a staggering and puzzling trend. Since the
demonstration of an etiological relationship between hepatitis B
virus infection and hepatocellular carcinoma, intensive research
has been con ducted in an effort to elucidate the role of the virus
in hepatocarcinogenesis. Though much progress has been made, a full
understanding of the molecular events leading to malignant
transformation of the hepatocyte will probably require many more
years of rigorous investigation. Chemical carcinogens and several
industrial pollutants may also be involved in the etiopathogenesis
of neoplastic liver disease."
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
You might also like..
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.